You have 9 free searches left this month | for more free features.

Mycobacterium avium Complex

Showing 1 - 25 of 5,810

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Drug Exposure and Minimum Inhibitory Concentration in Treatment

Not yet recruiting
  • Mycobacterium Avium Complex
  • +3 more
  • Drug exposure
  • Shanghai, China
    Shanghai Pulmonary Hospital
Apr 10, 2023

Mycobacterium Avium Complex Pulmonary Disease Trial in Seoul

Not yet recruiting
  • Mycobacterium Avium Complex Pulmonary Disease
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Jun 7, 2023

    Mycobacterium Avium Complex Pulmonary Disease Trial (Minocycline)

    Not yet recruiting
    • Mycobacterium Avium Complex Pulmonary Disease
    • (no location specified)
    May 15, 2023

    Mycobacterium Avium Complex Trial in Baltimore (Azithromycin)

    Recruiting
    • Mycobacterium Avium Complex
    • Baltimore, Maryland
      Johns Hopkins University School of Medicine
    Mar 7, 2022

    Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) Trial (Placebo, SPR720 500 mg, SPR720 1000 mg)

    Not yet recruiting
    • Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)
    • Placebo
    • +2 more
    • (no location specified)
    Aug 9, 2022

    Mycobacterium Avium Complex Trial in United States (Clofazimine, sugar pill)

    Recruiting
    • Mycobacterium Avium Complex
    • Denver, Colorado
    • +7 more
    Aug 18, 2022

    Pulmonary Mycobacterium Avium Complex Infection, Bronchiectasis, Lung Diseases Trial in United States (RHB-204, Placebo)

    Recruiting
    • Pulmonary Mycobacterium Avium Complex Infection
    • +2 more
    • Glendale, California
    • +24 more
    Jan 23, 2023

    Energy Metabolism for the Pulmonary Mycobacterium Avium Complex

    Completed
    • Pulmonary MAC
    • +2 more
      • Joyo, Kyoto, Japan
        National Hospital Organization Minami Kyoto Hospital
      Dec 26, 2021

      Nontuberculous Mycobacterial Lung Disease, Nontuberculous Mycobacterium Infection Trial in New York, Portland, Toronto

      Recruiting
      • Nontuberculous Mycobacterial Lung Disease
      • Nontuberculous Mycobacterium Infection
      • Hypertonic saline
      • +3 more
      • New York, New York
      • +2 more
      Jan 27, 2023

      Mycobacterium Avium Complex, Non-tuberculous Mycobacterium Pulmonary Disease Trial in United States (SPR720, Placebo, Open-label

      Terminated
      • Mycobacterium Avium Complex
      • Non-tuberculous Mycobacterium Pulmonary Disease
      • Altamonte Springs, Florida
      • +8 more
      Feb 3, 2022

      Mycobacterium Avium Complex, Nontuberculous Mycobacterium Infection Trial in Canada, United States (Azithromycin, Ethambutol,

      Recruiting
      • Mycobacterium Avium Complex
      • Nontuberculous Mycobacterium Infection
      • Loma Linda, California
      • +26 more
      Jan 18, 2023

      Lung Infection, Mycobacterium Avium Complex Trial in Amiens, Marseille (Clarithromycin 1000 MG, Azithromycin 250 mg, Rifampicin)

      Recruiting
      • Lung Infection
      • Mycobacterium Avium Complex
      • Clarithromycin 1000 MG
      • +3 more
      • Amiens, Picardie, France
      • +1 more
      Aug 23, 2021

      Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD) Trial in Japan (Bedaquiline, Clarithromycin, Ethambutol)

      Recruiting
      • Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)
      • Aichi, Japan
      • +42 more
      Jan 17, 2023

      Mycobacterium Avium-intracellulare Infection, HIV Trial in United States (Ethambutol HCl, Clarithromycin, Clofazimine)

      Completed
      • Mycobacterium Avium-intracellulare Infection
      • HIV Infections
      • Ethambutol hydrochloride
      • +3 more
      • San Francisco, California
      • +15 more
      Oct 28, 2021

      Mycobacterium Avium-intracellulare Infection, HIV Trial in Tanzania, United States (Indinavir sulfate, Ritonavir, Ethambutol

      Completed
      • Mycobacterium Avium-intracellulare Infection
      • HIV Infections
      • Indinavir sulfate
      • +4 more
      • Birmingham, Alabama
      • +33 more
      Oct 28, 2021

      Disease-Causing Bacteria in HIV-Infected Patients: A Substudy of

      Completed
      • Mycobacterium Avium-intracellulare Infection
      • +2 more
        • San Francisco, California
        • +14 more
        Oct 27, 2021

        Mycobacterium Avium-intracellulare Infection, HIV Trial in United States (Azithromycin)

        Completed
        • Mycobacterium Avium-intracellulare Infection
        • HIV Infections
        • San Francisco, California
        • +18 more
        Oct 27, 2021

        Mycobacterium Avium-intracellulare Infection, HIV Trial in Tanzania, United States (Clarithromycin, Rifabutin)

        Completed
        • Mycobacterium Avium-intracellulare Infection
        • HIV Infections
        • Birmingham, Alabama
        • +41 more
        Oct 28, 2021

        Non-Tuberculous Mycobacterial Pneumonia, Cystic Fibrosis, Mycobacterial Pneumonia Trial in Greenslopes (LungFit)

        Recruiting
        • Non-Tuberculous Mycobacterial Pneumonia
        • +4 more
        • LungFit
        • Greenslopes, Queensland, Australia
          Gallipoli Medical Research Foundation
        Dec 24, 2020

        MAC Lung Disease Trial in United States (Epetraborole, Placebo)

        Recruiting
        • MAC Lung Disease
        • Treatment Refractory MAC Lung Disease
        • Birmingham, Alabama
        • +40 more
        Jan 31, 2023

        Mycobacterium Infections, Nontuberculous Trial in Worldwide (ALIS, Azithromycin, Ethambutol)

        Active, not recruiting
        • Mycobacterium Infections, Nontuberculous
        • Birmingham, Alabama
        • +110 more
        Jan 23, 2023

        Nontuberculous Mycobacterium Infection, Mycobacterium Abscessus Infection Trial (Delpazolid)

        Not yet recruiting
        • Nontuberculous Mycobacterium Infection
        • Mycobacterium Abscessus Infection
        • (no location specified)
        Aug 21, 2023

        Mycobacterium Infections, Nontuberculous Trial (LAI (Liposomal Amikacin for Inhalation) 590 mg)

        Completed
        • Mycobacterium Infections, Nontuberculous
        • LAI (Liposomal Amikacin for Inhalation) 590 mg
        • (no location specified)
        Apr 22, 2020

        Glutathione-cyclodextrin Complex Absorption Trial in Pomona (Glutaryl Solution, Placebo Solution)

        Completed
        • Glutathione-cyclodextrin Complex Absorption
        • Glutaryl Solution
        • Placebo Solution
        • Pomona, California
          Western University of Health Sciences
        Jun 26, 2023

        HIV Infection, HIV-1 Infection, Mycobacterium Avium Complex (MAC) Trial in Ottawa (Rifabutin, Maraviroc)

        Completed
        • HIV Infection
        • +2 more
        • Ottawa, Ontario, Canada
          The Ottawa Hospital -General Campus
        Feb 25, 2020